Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

                World’s First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules  Kelowna, British Columbia – February 6, 2024 – TheNewswire - Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that dosing has begun in its fluorescently tagged DehydraTECH-semaglutide (“FTS”) rodent biodistribution study (the “Study”). Distribution of a drug once it enters the body can provide vital clues as to the understandi ...